February 13, 2018
China’s AI Agenda Advances
Are China’s ambitions to “lead the world” in artificial intelligence (AI) by 2030 credible? China’s rapid emergence as an AI powerhouse is often hyped and sensationalized, variously provoking alarm and enthusiasm that can sometimes overshadow the reality of real progress. At the same time, critical challenges remain in China’s quest to become “the world’s premier AI innovation center” and build up an AI industry of 1 trillion RMB (about $150 billion) in the process.
In China’s “rise” in AI, the active efforts of private enterprises have predated more recent policy support. However, since the State Council released the New Generation AI Development Plan in July 2017, there have been a number of indicators that its implementation is advancing throughout all levels of government. Although the future trajectory of its AI revolution remains to be seen, China is rapidly building momentum to harness the power of state support and the dynamism of private enterprises in a new model of innovation.
AI has only recently become a clear priority for Chinese leaders under the aegis of an agenda to transform China into a “nation of innovation.” For the 13th Five-Year Plan timeframe (2016-2020), China’s ambitions to transform itself into a superpower in science and technology are clear. In August 2016, the 13th Five-Year National Science and Technology Innovation Plan called for China to seize the “high ground” in international scientific development, launching a series of 15 “Science and Technology Innovation 2030 Megaprojects” that included both big data and intelligent manufacturing and robotics. At that point, AI was not explicitly included as a priority at that level, despite being mentioned in that and included in prior plans, such as the “Internet Plus” Artificial Intelligence Three-Year Action Implementation Plan, released in May 2016. Not until May 2017 did the Ministry of Science and Technology announce the decision to add “AI 2.0” to that initial lineup as a 16th megaproject.
Read the full op-ed in The Diplomat.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
Reports
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
Podcast
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
Commentary
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Reports
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko
